Dolutegravir intermediate-1 is a synthetic intermediate of Dolutegravir extracted from patent WO 2016125192 A2. Dolutegravir is an integrase inhibitor developed for the treatment of human immunodeficiency virus (HIV)-1 infection.
Molecular Weight:
315.28
Purity:
99.97
CAS Number:
[1335210-23-5]
Formula:
C13H17NO8
Target:
HIV
Application Notes:
Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted